Clinical Trials

Multiple MyelomaA Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Standard Regimens in Participants with Relapsed Refractory Multiple Myeloma (DURGA-4)
Not accepting volunteers
Evaluation of [11C]PyBic as a radioligand for Positron Emission Tomography imaging of Poly ADP-Ribose Polymerase 1 (PARP-1)
Not accepting volunteers
Diseases of the Endocrine SystemA PHASE 3, PARALLEL-GROUP TREATMENT, BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PEGTIBATINASE ADMINISTERED SUBCUTANEOUSLY IN ADDITION TO STANDARD OF CARE IN PARTICIPANTS WITH CLASSICAL HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA SYNTHASE DEFICIENCY (HARMONY)
Not accepting volunteers
ProstateFGCL-3246-112: A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients with Metastatic Castration-Resistant Prostate Cancer [Advarra IRB]
Not accepting volunteers
A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects with De Novo Coronary Lesions in Small Vessels
Not accepting volunteers